<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The transcription factor IRF-1 has been shown to function as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor </plain></SENT>
<SENT sid="1" pm="."><plain>Here we report that a significant proportion of the IRF-1 mRNA detected in <z:mpath ids='MPATH_458'>normal</z:mpath> human hematopoietic cells and cultured cell lines lacks exon 2 (containing the AUG initiation codon) and 3 as a result of exon skipping </plain></SENT>
<SENT sid="2" pm="."><plain>Surprisingly, when we examined the bone marrow and peripheral mononuclear cells from patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) or <z:hpo ids='HP_0001909'>leukemia</z:hpo> secondary to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, we could still detect the exon-skipped form but little or none of the intact IRF-1 mRNA </plain></SENT>
<SENT sid="3" pm="."><plain>This appears to be the result of accelerated exon skipping since we could find no mutations within the exons and splicing junctions from these patients </plain></SENT>
<SENT sid="4" pm="."><plain>The exon-skipped form of IRF-1 lacking exons 2 and 3 displayed neither DNA binding nor <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive activities </plain></SENT>
<SENT sid="5" pm="."><plain>Thus this accelerated exon skipping may cause the inactivation of IRF-1 and thereby contribute to the development of human <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> </plain></SENT>
</text></document>